Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Dec 7;9:1071. doi: 10.3389/fneur.2018.01071

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2018 Kaufmann, Haase, Proschmann, Ziemssen and Akgün.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Serological parameters during NAT treatment. Before each infusion started, blood samples were taken and analyzed in a certified medical laboratory. Analysis of serological parameters including ALAT (A), ASAT (B), gamma-GT (C), creatinine (D), and CRP (E) were included. Data are shown for baseline analysis (M0) and sixth months follow up (M6, M12, […], M72). Data are presented as mean ± standard deviation. Dotted line indicates the reverence range for men for ALAT and ASAT at a value of 0.85 μmol/s*L and for gamma-GT at 1.2 μmol/s*L. Broken line indicates reverence range for women for ALAT and ASAT at a value of 0.6 μmol/s*L and for gamma-GT at 0.7 μmol/s*L. There were no statistical significant changes.